Melissa Chapman is a seasoned product and clinical technology leader at Endpoint Clinical, with more than two decades of experience shaping solutions that strengthen the execution of global clinical trials. Her work centers on designing intelligent, user‑centric systems that streamline study operations, elevate data quality, and support better decision-making across the trial lifecycle.
Melissa is particularly focused on translating emerging technologies—including practical, real‑world applications of AI—into tools that meaningfully enhance automation, site and sponsor workflows, and patient‑centric outcomes.
Recognized for her collaborative leadership style, she partners closely with cross‑functional teams to break down complex operational challenges and deliver scalable innovations. Her strategic approach and deep understanding of clinical development make her a trusted voice on how technology can drive measurable impact in modern trial delivery.